Shopping Cart 0
Cart Subtotal
USD 0

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

AcelRx Pharmaceuticals Inc (ACRX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company's lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. Its pipeline also includes Zalviso, a drug and device combination product for management of moderate to severe acute pain in adults. AcelRx developed a proprietary, non-invasive, sublingual formulation technology to deliver its highly lipophilic drugs. The company commercializes its EC approved Zalviso under license agreement with Grunenthal in various European Union countries and Australia. AcelRx is headquartered in Redwood City, California, the US.

AcelRx Pharmaceuticals Inc Key Recent Developments

Aug 02,2018: AcelRx Pharmaceuticals reports second quarter 2018 financial results

Jul 11,2018: AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock

May 09,2018: AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results

Mar 27,2018: AcelRx Pharmaceuticals Names John Saia As General Counsel

Mar 08,2018: AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

AcelRx Pharmaceuticals Inc-Key Facts 6

AcelRx Pharmaceuticals Inc-Key Employees 7

AcelRx Pharmaceuticals Inc-Key Employee Biographies 8

AcelRx Pharmaceuticals Inc-Major Products and Services 10

AcelRx Pharmaceuticals Inc-History 11

AcelRx Pharmaceuticals Inc-Company Statement 12

AcelRx Pharmaceuticals Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

AcelRx Pharmaceuticals Inc-Business Description 15

R&D Overview 15

AcelRx Pharmaceuticals Inc-Corporate Strategy 16

AcelRx Pharmaceuticals Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

AcelRx Pharmaceuticals Inc-Strengths 17

AcelRx Pharmaceuticals Inc-Weaknesses 18

AcelRx Pharmaceuticals Inc-Opportunities 19

AcelRx Pharmaceuticals Inc-Threats 20

AcelRx Pharmaceuticals Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

AcelRx Pharmaceuticals Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Aug 02, 2018: AcelRx Pharmaceuticals reports second quarter 2018 financial results 31

Jul 11, 2018: AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock 32

May 09, 2018: AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results 33

Mar 08, 2018: AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results 34

Nov 09, 2017: AcelRx Pharmaceuticals Reports Third Quarter 2017 Financial Results 35

Aug 01, 2017: AcelRx Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update 36

Jul 19, 2017: AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer 38

Jun 01, 2017: AcelRx's pain management drug selected for Red Dot Design Award 39

May 08, 2017: AcelRx Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update 40

Mar 02, 2017: AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results 42

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

AcelRx Pharmaceuticals Inc, Performance Chart (2013-2017) 25

AcelRx Pharmaceuticals Inc, Ratio Charts 27

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29


List Of Table

List of Tables

AcelRx Pharmaceuticals Inc, Key Facts 6

AcelRx Pharmaceuticals Inc, Key Employees 7

AcelRx Pharmaceuticals Inc, Key Employee Biographies 8

AcelRx Pharmaceuticals Inc, Major Products and Services 10

AcelRx Pharmaceuticals Inc, History 11

AcelRx Pharmaceuticals Inc, Subsidiaries 13

AcelRx Pharmaceuticals Inc, Key Competitors 21

AcelRx Pharmaceuticals Inc, Ratios based on current share price 22

AcelRx Pharmaceuticals Inc, Annual Ratios 23

AcelRx Pharmaceuticals Inc, Annual Ratios (Cont...1) 24

AcelRx Pharmaceuticals Inc, Interim Ratios 26

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

AcelRx Pharmaceuticals Inc, Recent Deals Summary 30

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 47

Efficiency Ratios 47

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

AcelRx Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Trevena Inc

Purdue Pharma LP

Egalet Corp

Collegium Pharmaceutical Inc

Cara Therapeutics Inc